首页> 外文期刊>Transplantation Proceedings >Transplant renal artery stenosis: association with acute vascular rejection.
【24h】

Transplant renal artery stenosis: association with acute vascular rejection.

机译:移植肾动脉狭窄:与急性血管排斥反应相关。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Transplant renal artery stenosis, the prevalence of which varies from 2% to 12%, is an important cause of hypertension and allograft dysfunction. We sought to determine the clinical characteristics of this disorder, assessing, predisposing factors, establishing treatment options, and examining patient outcomes. PATIENTS AND METHODS: Among 321 renal allograft recipients between November 1996 and December 2004, six patients were identified with this finding. We analyzed their clinical data before and after treatment compared with the 315 recipients face of the disorder. RESULTS: The six patients with the disorder were diagnosed within the first year (2 to 8 months; median 5.5 months). All patients displayed renal dysfunction, peripheral edema, and new-onset or uncontrolled hypertension at presentation. Abnormal Doppler findings were observed in 5 (83.3%) patients. The hemodynamically significant stenosis was successfully treated with percutaneous transluminal angioplasty (PTA) in all six. However, 3 (50%) patients displayed recurrent stenosis requiring a second PTA. The mean serum creatinine level decreased from a pre-PTA value of 4.4 +/- 1.8 mg/dL to a 1-month post-PTA value of 2.2 +/- 0.5 mg/dL (P = .027). Patients had no significant improvement in mean systolic and diastolic pressure. Vascular acute rejection episodes were more frequent among the affected than the control group (3/6; 50% vs 18/315; 5.7%; P < .001). No differences were found in age, sex, donor type, etiology of renal disease, immunosuppression, acute tubular necrosis, acute cellular rejection, cold ischemia time, or HLA matching. CONCLUSION: Transplant renal artery stenosis is a common cause of hypertension and renal allograft dysfunction. Acute vascular rejection is associated with this disorder.
机译:背景:移植肾动脉狭窄的发生率从2%到12%不等,是导致高血压和同种异体移植功能障碍的重要原因。我们试图确定该疾病的临床特征,评估,诱发因素,建立治疗方案并检查患者预后。患者与方法:在1996年11月至2004年12月之间的321名同种异体肾移植受者中,有6名患者被发现具有这一发现。我们比较了315名接受治疗者的疾病治疗前后的临床资料。结果:六名患有该疾病的患者在第一年(2至8个月;中位数5.5个月)被诊断出。所有患者在出现时均表现出肾功能不全,外周水肿和新发或不受控制的高血压。在5例(83.3%)的患者中观察到了异常的多普勒检查结果。在全部六个患者中,经皮腔内血管成形术(PTA)成功治疗了血液动力学显着的狭窄。但是,有3名(50%)患者显示出狭窄的狭窄,需要第二次PTA。平均血清肌酐水平从PTA前的4.4 +/- 1.8 mg / dL下降到PTA后1个月的2.2 +/- 0.5 mg / dL(P = .027)。患者的平均收缩压和舒张压没有明显改善。患血管急性排斥反应的发生率比对照组高(3/6; 50%比18/315; 5.7%; P <.001)。在年龄,性别,供体类型,肾脏疾病的病因,免疫抑制,急性肾小管坏死,急性细胞排斥,冷缺血时间或HLA匹配方面未发现差异。结论:移植肾动脉狭窄是高血压和同种异体肾功能不全的常见原因。急性血管排斥反应与这种疾病有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号